New drug trial aims to slow kidney damage in IgA nephropathy patients
NCT ID NCT05852938
Summary
This study is testing whether the drug BION-1301 can help adults with IgA nephropathy, a kidney disease that can lead to kidney failure. About 383 participants will receive either the drug or a placebo injection every two weeks for two years. The main goal is to see if the drug reduces protein in the urine, a key sign of kidney damage, and slows the decline in kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOGLOBULIN A NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Capital District Renal Physicians
Clifton Park, New York, 12065, United States
-
Cleveland Clinic-9500 Euclid Ave
Cleveland, Ohio, 44109-1900, United States
-
Columbia Nephrology Associates , P.A. - Columbia
Columbia, South Carolina, 29203-6476, United States
-
DaVita Clinical Research
El Paso, Texas, 79925, United States
-
Dallas Renal Group - 1411 N Beckley Ave
Dallas, Texas, 75230, United States
-
Dallas Renal Group - Waxachie - 2460 N. I-35
Dallas, Texas, 75237-3461, United States
-
Denver Nephrology Research Division
Denver, Colorado, 80230-6441, United States
-
East Texas Nephrology Associates
Lufkin, Texas, 75904-3132, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029-6504, United States
-
Intermed Consultants
Edina, Minnesota, 55435-2129, United States
-
Knoxville Kidney Center, PLLC - Frenova F1
Knoxville, Tennessee, 37923, United States
-
Nephrology Associales of Northern Illinois and Indiana
Hinsdale, Illinois, 60521-3640, United States
-
Nephrology Associates PC - Flushing
Flushing, New York, 11355-5045, United States
-
Nephrology Associates of Northern Illinois and Indiana - 7836 W Jefferson Blvd
Fort Wayne, Indiana, 46804, United States
-
Nephrology Associates of Northern Virginia-8501 Arlington Blvd
Fairfax, Virginia, 22033-1907, United States
-
Nephrology Consultants, LLC
Huntsville, Alabama, 35805-4104, United States
-
NorthShore University HealthSystem
Evanston, Illinois, 60201-1700, United States
-
Northeast Clinical Research Center, LLC
Bethlehem, Pennsylvania, 18017-2159, United States
-
Novartis Investigative Site
La Plata, Buenos Aires, B1902COS, Argentina
-
Novartis Investigative Site
Catamarca, Catamarca Province, K4700, Argentina
-
Novartis Investigative Site
Barracas, Ciudad Autónoma de BuenosAires, C1280AEB, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, S2013DTC, Argentina
-
Novartis Investigative Site
Santa Fe, Santa Fe Province, S3000EPV, Argentina
-
Novartis Investigative Site
Buenos Aires, C1425, Argentina
-
Novartis Investigative Site
Gosford, New South Wales, 2250, Australia
-
Novartis Investigative Site
Kogarah, New South Wales, 2217, Australia
-
Novartis Investigative Site
Liverpool, New South Wales, 2170, Australia
-
Novartis Investigative Site
Penrith, New South Wales, 2750, Australia
-
Novartis Investigative Site
St Leonards, New South Wales, 2065, Australia
-
Novartis Investigative Site
Cairns North, Queensland, 4870, Australia
-
Novartis Investigative Site
Box Hill, Victoria, 3128, Australia
-
Novartis Investigative Site
St Albans, Victoria, 3021, Australia
-
Novartis Investigative Site
Bonheiden, Antwerpen, 2820, Belgium
-
Novartis Investigative Site
Ghent, Oost-Vlaanderen, 9000, Belgium
-
Novartis Investigative Site
Roeselare, West-Vlaanderen, 8800, Belgium
-
Novartis Investigative Site
Liège, Liège, Belgium
-
Novartis Investigative Site
Lodelinsart, 6042, Belgium
-
Novartis Investigative Site
Woluwe-Saint-Lambert, 1200, Belgium
-
Novartis Investigative Site
Santana, Amapá, 68925-000, Brazil
-
Novartis Investigative Site
Belo Horizonte, Minas Gerais, 30130-100, Brazil
-
Novartis Investigative Site
Maringá, Paraná, 87013-040, Brazil
-
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, 90035-074, Brazil
-
Novartis Investigative Site
Joinville, Santa Catarina, 89227-680, Brazil
-
Novartis Investigative Site
São Bernardo do Campo, São Paulo, 09780-000, Brazil
-
Novartis Investigative Site
São Paulo, São Paulo, 01323-001, Brazil
-
Novartis Investigative Site
São Paulo, 04023-900, Brazil
-
Novartis Investigative Site
Vancouver, British Columbia, V5Z 1M9, Canada
-
Novartis Investigative Site
Brampton, Ontario, L6Z 4N5, Canada
-
Novartis Investigative Site
East York, Ontario, M4C 5T2, Canada
-
Novartis Investigative Site
London, Ontario, N6A 5A5, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5G 2N2, Canada
-
Novartis Investigative Site
Greenfield Park, Quebec, J4V 2H1, Canada
-
Novartis Investigative Site
Montreal, Quebec, H1T 2M4, Canada
-
Novartis Investigative Site
Hefei, Anhui, 230601, China
-
Novartis Investigative Site
Beijing, Beijing Municipality, 100034, China
-
Novartis Investigative Site
Foshan, Guangdong, 528000, China
-
Novartis Investigative Site
Guangzhou, Guangdong, 510080, China
-
Novartis Investigative Site
Guangzhou, Guangdong, 510280, China
-
Novartis Investigative Site
Shenzhen, Guangdong, 518036, China
-
Novartis Investigative Site
Nanning, Guangxi, 530021, China
-
Novartis Investigative Site
Guiyang, Guizhou, 550002, China
-
Novartis Investigative Site
Wuhan, Hubei, 430060, China
-
Novartis Investigative Site
Nanjing, Jiangsu, 210029, China
-
Novartis Investigative Site
Nantong, Jiangsu, 226001, China
-
Novartis Investigative Site
Wuxi, Jiangsu, 214023, China
-
Novartis Investigative Site
Nanchang, Jiangxi, 330006, China
-
Novartis Investigative Site
Jinan, Shandong, 250021, China
-
Novartis Investigative Site
Qingdao, Shandong, 266005, China
-
Novartis Investigative Site
Shanghai, Shanghai Municipality, 200040, China
-
Novartis Investigative Site
Taiyuan, Shanxi, 030001, China
-
Novartis Investigative Site
Taiyuan, Shanxi, 650000, China
-
Novartis Investigative Site
Chengdu, Sichuan, 610072, China
-
Novartis Investigative Site
Ürümqi, Xinjiang, 830001, China
-
Novartis Investigative Site
Wulumuji, Xinjiang, 830054, China
-
Novartis Investigative Site
Hangzhou, Zhejiang, 310009, China
-
Novartis Investigative Site
Taizhou, Zhejiang, 317000, China
-
Novartis Investigative Site
Zagreb, City of Zagreb, 10000, Croatia
-
Novartis Investigative Site
Biškupec Zelinski, 10380, Croatia
-
Novartis Investigative Site
Rijeka, 51000, Croatia
-
Novartis Investigative Site
Vinkovci, 32100, Croatia
-
Novartis Investigative Site
Prague, Praha, Hlavní Mesto, 128 08, Czechia
-
Novartis Investigative Site
Nîmes, Gard, 30029, France
-
Novartis Investigative Site
Lille, Nord, 59000, France
-
Novartis Investigative Site
Lyon, Rhône, 69437, France
-
Novartis Investigative Site
Grenoble, 38043, France
-
Novartis Investigative Site
Paris, 75010, France
-
Novartis Investigative Site
Paris, 75015, France
-
Novartis Investigative Site
Augsburg, Bavaria, 86156, Germany
-
Novartis Investigative Site
Hanover, Lower Saxony, 30459, Germany
-
Novartis Investigative Site
Hanover, Lower Saxony, 30625, Germany
-
Novartis Investigative Site
Mainz, Rhineland-Palatinate, 55131, Germany
-
Novartis Investigative Site
Trier, Rhineland-Palatinate, 54292, Germany
-
Novartis Investigative Site
Magdeburg, Saxony-Anhalt, 39120, Germany
-
Novartis Investigative Site
Jena, Thuringia, 07747, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Pátrai, Achaïa, 265 04, Greece
-
Novartis Investigative Site
Athens, Attica, 12462, Greece
-
Novartis Investigative Site
Kalamaria, Thessaloniki, 551 34, Greece
-
Novartis Investigative Site
Heralkion, 71409, Greece
-
Novartis Investigative Site
Ioannina, 450 01, Greece
-
Novartis Investigative Site
Ioannina, 455 00, Greece
-
Novartis Investigative Site
Thessaloniki, 546 29, Greece
-
Novartis Investigative Site
Hyderabad, Andhra Pradesh, 500084, India
-
Novartis Investigative Site
Chandigarh, Chandigarh, 160012, India
-
Novartis Investigative Site
Faridabad, Haryana, 121002, India
-
Novartis Investigative Site
Bengaluru, Karnataka, 560004, India
-
Novartis Investigative Site
Trivandrum, Kerala, 695011, India
-
Novartis Investigative Site
Jaipur, Rajasthan, 302001, India
-
Novartis Investigative Site
Jaipur, Rajasthan, 302017, India
-
Novartis Investigative Site
Vellore, Tamil Nadu, 632004, India
-
Novartis Investigative Site
Lucknow, Uttar Pradesh, 226005, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700014, India
-
Novartis Investigative Site
Dehradun, 248001, India
-
Novartis Investigative Site
Beersheba, Southern District, 84101, Israel
-
Novartis Investigative Site
Holon, Tel Aviv, 58000, Israel
-
Novartis Investigative Site
Ramat Gan, Tel Aviv, 52394, Israel
-
Novartis Investigative Site
Be’er Ya‘aqov, 70300, Israel
-
Novartis Investigative Site
Ramat Gan, 5262100, Israel
-
Novartis Investigative Site
Tel Aviv, 64239, Israel
-
Novartis Investigative Site
Bari, Apulia, 70124, Italy
-
Novartis Investigative Site
Foggia, Apulia, 71100, Italy
-
Novartis Investigative Site
Naples, Campania, 80131, Italy
-
Novartis Investigative Site
Modena, Emilia-Romagna, 41124, Italy
-
Novartis Investigative Site
Trieste, Friuli Venezia Giulia, 34149, Italy
-
Novartis Investigative Site
Pavia, Lombardy, 27100, Italy
-
Novartis Investigative Site
Ranica, Lombardy, 24020, Italy
-
Novartis Investigative Site
Kasugai-Shi, Aiti, 486-0804, Japan
-
Novartis Investigative Site
Toyoake-shi, Aiti, 470-1192, Japan
-
Novartis Investigative Site
Urayasu-Shi, Chiba, 279-0021, Japan
-
Novartis Investigative Site
Sapporo, Hokkaidô, 060-8604, Japan
-
Novartis Investigative Site
Kitakyushu, Hukuoka, 802-8555, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 236-0004, Japan
-
Novartis Investigative Site
Kashihara, Nara, 634-8522, Japan
-
Novartis Investigative Site
Nara, Nara, 630-8581, Japan
-
Novartis Investigative Site
Osaka, Osaka, 558-0056, Japan
-
Novartis Investigative Site
Bunkyo-Ku, Tokyo, 113-8431, Japan
-
Novartis Investigative Site
Hachioji-Shi, Tokyo, 192-0071, Japan
-
Novartis Investigative Site
Minato-Ku, Tokyo, 105-8471, Japan
-
Novartis Investigative Site
Shinjuku-Ku, Tokyo, 162-0054, Japan
-
Novartis Investigative Site
Chiba, 260-8712, Japan
-
Novartis Investigative Site
Niigata, 951-8520, Japan
-
Novartis Investigative Site
Okayama, 700-8558, Japan
-
Novartis Investigative Site
Tokyo, 105-8470, Japan
-
Novartis Investigative Site
Yufu-Shi, Ôita, 879-5503, Japan
-
Novartis Investigative Site
Kuantan, Pahang, 25100, Malaysia
-
Novartis Investigative Site
Sibu, Sarawak, 96000, Malaysia
-
Novartis Investigative Site
Kajang, Selangor, 43000, Malaysia
-
Novartis Investigative Site
Kuala Lumpur, WilayahPersekutuan KualaLumpur, 50586, Malaysia
-
Novartis Investigative Site
Kuala Lumpur, WilayahPersekutuan KualaLumpur, 59100, Malaysia
-
Novartis Investigative Site
Chihuahua, Chiapas, 31217, Mexico
-
Novartis Investigative Site
Barrio Belisario Domínguez Secc, Mexico City, 14080, Mexico
-
Novartis Investigative Site
Oaxaca, Mexico City, 68000, Mexico
-
Novartis Investigative Site
Aguascalientes, 20259, Mexico
-
Novartis Investigative Site
Chihuahua City, 64060, Mexico
-
Novartis Investigative Site
Monterrey, 64060, Mexico
-
Novartis Investigative Site
Dongan-Gu, Anyang-Si, Gyeonggido, 14068, South Korea
-
Novartis Investigative Site
Guri-si, Gyeonggido, South Korea
-
Novartis Investigative Site
Uijeongbu-si, Gyeonggido, 11765, South Korea
-
Novartis Investigative Site
Jongno-gu, Seoul Teugbyeolsi, 03080, South Korea
-
Novartis Investigative Site
Seodaemun-gu, Seoul Teugbyeolsi, 03722, South Korea
-
Novartis Investigative Site
Seongbuk-Gu, Seoul Teugbyeolsi, 02841, South Korea
-
Novartis Investigative Site
Cheonan, South Korea
-
Novartis Investigative Site
Daejeon, 301721, South Korea
-
Novartis Investigative Site
Seoul, 06973, South Korea
-
Novartis Investigative Site
Manises, Valencia, 46940, Spain
-
Novartis Investigative Site
Barcelona, 8035, Spain
-
Novartis Investigative Site
Girona, 17007, Spain
-
Novartis Investigative Site
Lleida, 25198, Spain
-
Novartis Investigative Site
Lugo, 27880, Spain
-
Novartis Investigative Site
Madrid, 28007, Spain
-
Novartis Investigative Site
Madrid, 28041, Spain
-
Novartis Investigative Site
Seville, 41009, Spain
-
Novartis Investigative Site
Keelung, Keelung, 204, Taiwan
-
Novartis Investigative Site
Changhua County, 50006, Taiwan
-
Novartis Investigative Site
Hsinchu, Taiwan
-
Novartis Investigative Site
Hualien City, 970, Taiwan
-
Novartis Investigative Site
Kaohsiung City, Taiwan
-
Novartis Investigative Site
Tainan, 704, Taiwan
-
Novartis Investigative Site
Taipei, 100, Taiwan
-
Novartis Investigative Site
Taipei, 116, Taiwan
-
Novartis Investigative Site
Bornova, İzmir, 35100, Turkey (Türkiye)
-
Novartis Investigative Site
İzmit, Kocaeli, 41380, Turkey (Türkiye)
-
Novartis Investigative Site
Antalya, 07070, Turkey (Türkiye)
-
Novartis Investigative Site
Kayseri, 38039, Turkey (Türkiye)
-
Novartis Investigative Site
Bristol, Bristol, City of, BS10 5NB, United Kingdom
-
Novartis Investigative Site
Brighton, East Sussex, BN2 5BE, United Kingdom
-
Novartis Investigative Site
Salford, Lancashire, M6 8HD, United Kingdom
-
Novartis Investigative Site
Leicester, Leicestershire, LE5 4PW, United Kingdom
-
Novartis Investigative Site
London, London, City of, SE5 9RS, United Kingdom
-
Novartis Investigative Site
Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
-
OHSU - Oregon Clinical and Translational Research Institute
Portland, Oregon, 97239, United States
-
Swedish Center for Comprehensive Care
Seattle, Washington, 98104, United States
-
University Of Iowa Hospitals And Clinics
Iowa City, Iowa, 52242-1009, United States
-
University of Alabama at Birmingham: The Kirklin Clinic
Birmingham, Alabama, 35233-1926, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Cincinnati College of Medicine - 231 Albert Sabin Way
Cincinnati, Ohio, 45267-2827, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Texas MD Anderson Cancer Center-1155 Pressler
Houston, Texas, 77030-2348, United States
-
Valiance Clinical Research
South Gate, California, 90280-5219, United States
-
Vida Medical Centers - Pembroke Pines
Pembroke Pines, Florida, 33023-2213, United States
Conditions
Explore the condition pages connected to this study.